Carbazitaxel injection and preparation method thereof
A cabazitaxel and injection technology, which is applied in the field of medicine, can solve the problems of difficult filtration and filling processes, difficult dispersing and dissolving of raw materials, complicated use steps, etc., and achieves the effects of drug-free time limit, long stability time and simple use method.
A cabazitaxel and injection technology, which is applied in the field of medicine, can solve the problems of difficult filtration and filling processes, difficult dispersing and dissolving of raw materials, complicated use steps, etc., and achieves the effects of drug-free time limit, long stability time and simple use method.
CN110840831AActive Publication Date: 2020-02-28KINDOS PHARM CO LTD +1
Image
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0025] A cabazitaxel injection comprises the following components by mass: 10 parts of cabazitaxel, 200 parts of polysorbate 80, 400 parts of polyethylene glycol and 390 parts of ethanol.
[0026] The molecular weight of the polyethylene glycol is 700.
Embodiment 2
[0028] A cabazitaxel injection comprises the following components by mass: 10 parts of cabazitaxel, 270 parts of polysorbate 80, 500 parts of polyethylene glycol and 220 parts of ethanol.
[0029] The molecular weight of the polyethylene glycol is 800.
Embodiment 3
[0031] A cabazitaxel injection comprises the following components by mass: 10 parts of cabazitaxel, 230 parts of polysorbate 80, 450 parts of polyethylene glycol and 310 parts of ethanol.
[0032] The molecular weight of the polyethylene glycol is 500.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More Abstract
The invention provides a cabazitaxel injection. The cabazitaxel injection comprises the following components in parts by mass: 10 parts of cabazitaxel, 200-270 parts of polysorbate 80, 400-500 parts of polyethylene glycol and 1,000 parts of ethanol. The product is good in stability, easy to filter and fill, and convenient to use in clinic.
Description
technical field [0001] The invention relates to the technical field of medicine, in particular to a cabazitaxel injection. Background technique [0002] Cabazitaxel is a second-line chemotherapy drug for the treatment of prostate cancer recommended by the NCCN guidelines in the United States, and it is a chemical semi-synthetic taxane-like small molecule compound. The currently marketed Cabazitaxel injection is a liquid injection. According to the FDA Orange Book, the original manufacturer is Sanofi-aventis U.S. LLC. This product is packaged in combination, one bottle is 60mg / 1.5mL cabazitaxel-polysorbate 80 solution; one bottle is diluent, 13% ethanol-water. Before clinical use, dilute the cabazitaxel solution with 13% ethanol-water. After dilution, the drug solution needs to be diluted in the second step within 30 minutes, otherwise precipitation will occur. There are the following defects: [0003] 1) The solvent polysorbate 80 is a viscous liquid. If the raw material ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
28 Feb 2020
Publication
CN110840831A
- IPC
- A61K9/08; A61K47/10; A61K47/26; A61K31/337; A61P35/00
- CPC
- A61K9/0019; A61K9/08; A61K31/337; A61K47/10; A61K47/26; A61P35/00
- Inventors
- 李娜; 李囿林